吉利德科学Gilead Sciences (GILD) 2018年年度报告「NASDAQ」.pdf

1、 UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington,D.C.20549 FORM 10-K(Mark One)ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934For the fiscal year ended December 31,2018oroTRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1

2、934For the transition period from to Commission File No.000-19731 GILEAD SCIENCES,INC.(Exact name of registrant as specified in its charter)Delaware94-3047598(State or Other Jurisdiction of Incorporation or Organization)(I.R.S.Employer Identification No.)333 Lakeside Drive,Foster City,California9440

3、4(Address of principal executive offices)(Zip Code)Registrants telephone number,including area code:650-574-3000 SECURITIES REGISTERED PURSUANT TO SECTION 12(b)OF THE ACT:Title of each class Name of each exchange on which registered Common Stock,$0.001 par value per shareThe Nasdaq Global Select Mar

4、ketSECURITIES REGISTERED PURSUANT TO SECTION 12(g)OF THE ACT:NONE Indicate by check mark if the registrant is a well-known seasoned issuer,as defined in Rule 405 of the Securities Act.Yes x No Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section

5、15(d)of the Act.Yes No xIndicate by check mark whether the registrant(1)has filed all reports required to be filed by Section 13 or 15(d)of the Securities Exchange Act of 1934 during the preceding 12months(or for such shorter period that the registrant was required to file such reports),and(2)has be

6、en subject to such filing requirements for the past 90 days.Yes No Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T(232.405of this chapter)during the preceding 12 months(or for such